Benzodiazepine use in Belgian nursing homes: A closer look into indications and dosages

European Journal of Clinical Pharmacology

Volumn 68, Issue 5, 2012, Pages 833-844

  Bourgeois, Jolyce ^a   Elseviers, Monique M ^a,b   Azermai, Majda ^a   Van Bortel, Luc ^a   Petrovic, Mirko ^a,c   Vander Stichele, Robert R ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Aged; Benzodiazepines; Drug utilisation; Pharmacoepidemiology

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; LORAZEPAM; LORMETAZEPAM; PRAZEPAM; ZOLPIDEM; ZOPICLONE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BELGIUM; CONSTIPATION; DEMENTIA; DEPRESSION; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG USE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PAIN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE;

AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANXIETY; BELGIUM; BENZODIAZEPINES; CONSTIPATION; CROSS-SECTIONAL STUDIES; DEPRESSION; DRUG UTILIZATION; FEMALE; HOMES FOR THE AGED; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MEDICAL RECORDS; MIDDLE AGED; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PSYCHOMOTOR AGITATION; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84864285232     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1188-z     Document Type: Article

References (61)

1. Azermai M, Elseviers M, Petrovic M, Van Bortel L, Stichele RV (2011) Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol. doi:10.1002/hup.1160
2. Gobert M, D'Hoore W (2005) Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatr 20(8):712-721. doi:10.1002/gps.1349 (Pubitemid 41158715)
3. Hosia-Randell H, Pitkala K (2005) Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22(9):793-800
4. Petek Ster M, Cedilnik Gorup E (2011) Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study. Croat Med J 52(1):16-24
5. Ashton H (1994) Guidelines for the rational use of benzodiazepines - when and what to use. Drugs 48(1):25-40
6. Neutel CI (2005) The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry 17(3):189-197. doi:10.1080/09540260500071863 (Pubitemid 40827296)
7. Canadian Agency for Drugs and Technologies in Health (CADTH) (2010) Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines. http://www.cadth.ca/media/pdf:M0022- Benzodiazepines-Elderly.pdf. Accessed 10 Aug 2011
8. National Institute for Health an Clinical Excellence (NICE) (2011) Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. http//www.nice.org.uk/nicemedia/live/13314/52599/52599.pdf. Accessed 10 Aug 2011
9. Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T, Galan C (2007) Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol 21 (7):774-782. doi:10.1177/0269881107077355 (Pubitemid 47437920)
10. Beland SG, Preville M, Dubois MF, Lorrain D, Voyer P, Bosse C, Grenier S, Moride Y (2011) The association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatr 26(9):908-915. doi:10.1002/gps.2623
11. Lader M, Tylee A, Donoghue J (2009) Withdrawing benzodiazepines in primary care. CNS Drugs 23(1):19-34. doi:10.2165/0023210-200923010-00002
12. Voyer P, Preville M, Cohen D, Berbiche D, Beland SG (2010) The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging 29(2):205-213. doi:10.1017/S0714980810000115
13. Verdoux H, Lagnaoui R, Begaud B (2005) Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 35(3):307-315. doi:10.1017/ s0033291704003897 (Pubitemid 40372470)
14. Wu CS, Wang SC, Chang IS, Lin KM (2009) The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am J Geriatr Psychiatry 17(7):614-620
15. Barker MJ, Greenwood KM, Jackson M, Crowe SF (2004) Cognitive effects of long-term benzodiazepine use - a meta-analysis. Cns Drugs 18(1):37-48 (Pubitemid 38197758)
16. Klotz U (1998) Effect of age on pharmacokinetics and pharmaco-dynamics in man. Int J Clin Pharmacol Therapeut 36(11):581-585 (Pubitemid 28519895)
17. Petrovic M, Mariman A, Warie H, Afschrift M, Pevernagie D (2003) Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 58(1):27-36 (Pubitemid 36396266)
18. Madhusoodanan SBOJ (2004) Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 3(5):485-493
19. Cook PJ, Huggett A, Graham-Pole R, Savage IT, James IM (1983) Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. Br Med J (Clin Res Ed) 286(6359):100-102 (Pubitemid 13147571)
20. Mustard CA, Mayer T (1997) Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol 145(8):738-745 (Pubitemid 27175285)
21. The British National Formularium (BNF). British Medical Association and the Royal Pharmaceutical Society. http://bnf.org:bnf:index.htm. Accessed 10 Aug 2011
22. KNMP (Royal Dutch Society of Pharmacy) (2009) Informatorium Medicametorum. Koninklijke Nederlandse Maatschappij ter bevordering van de Farmacie. www.knmp.nl. Accessed 8 June 2011
23. Sweetman SC (ed) Martindale: the complete drug reference, 36th ed. Pharmaceutical Press, London
24. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716-2724. doi:10.1001/archinte.163.22.2716163/22/2716 (Pubitemid 37517412)
25. Rancourt CMJ, Baillargeon L, Verreault R, Laurin D, Grégoire JP (2004) Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 4:9
26. Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63(8):725-731. doi:10.1007/s00228-007-0324-2 (Pubitemid 47052052)
27. Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, Mitchell SL (2010) Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry 18 (12):1078-1092. doi:10.1097/JGP.0b013e3181d6c0c6
28. Holmquist IB, Svensson B, Hoglund P (2003) Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 59(8-9):669-676. doi:10.1007/s00228-003-0679-y (Pubitemid 37494537)
29. Elseviers MVSR, Soenen K, Gobert M, Van Bortel L, Van De Voorde C (2010) Drug utilisation in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidemiol Drug Safety 19:1041-1048
30. Katz S, Akpom CA (1976) 12. Index of ADL. Med Care 14(5 Suppl):116-118
31. WHO Collaborating Centre for Drug Statistics Methodology (2009) ATC/DD Dsystem, http://www.whocc.no. Accessed 20 June 2011
32. Westbury J, Jackson S, Gee P, Peterson G (2010) An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUse project. Int Psychogeriatr 22(1):26-36. doi:10.1017/s1041610209991128
33. Bartlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, du Berger R (2004) Longitudinal patterns of new benzodiazepine use in the elderly. Pharmacoepidemiol Drug Saf 13(10):669-682. doi:10.1002/pds.908 (Pubitemid 39378276)
34. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Therapeut 46(2):72-83 (Pubitemid 351233792)
35. BCFI (Belgian Centre for Pharmacotherapeutic Information) (2010) Home page. http://www.bcfi.be/. Accessed 8 June 2011
36. B Terluin FBVH, K Van der Meer, GJH Neomagus, J Hekman, L P J Aulbers, J S Starreveld and M H Grol (2009) NHG-Standaarden Angststoornissen In: NHG-Standaarden voor huisartsened. Nederlandse huisartsen genootschap
37. Morin AK (2006) Strategies for treating chronic insomnia. Am J Manag Care 12(8 Suppl):S230-S245 (Pubitemid 43764994)
38. van Vliet P, van der Mast RC, van den Brock M, Westendorp RGJ, de Craen AJM (2009) Use of benzodiazepines, depressive symptoms and cognitive function in old age. Int J Geriatr Psychiatr 24 (5):500-508. doi:10.1002/gps.2143
39. Kripke DF (2007) Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 7:42. doi:10.1186/1471-244X-7-42 (Pubitemid 47506059)
40. Bliwise DL (2004) Sleep disorders in Alzheimer's disease and other dementias. Clin Cornerstone 6(Suppl 1A):S16-S28 (Pubitemid 38786663)
41. Cook JM, Marshall R, Masci C, Coyne JC (2007) Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 22(3):303-307. doi:10.1007/s11606-006-0021-3 (Pubitemid 46941221)
42. Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7(5):541-547. doi:10.1038/8786587865 (Pubitemid 32448319)
43. Cloos JM, Ferreira V (2009) Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 22(1):90-95. doi:10.1097/YCO.0b013e32831a473d
44. Ruths S, Straand J, Nygaard HA (2003) Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 12(3):176-180 (Pubitemid 36723943)
45. Berdot S, Bertrand M, Dartigues JF, Fourrier A, Tavernier B, Ritchie K, Alperovitch A (2009) Inappropriate medication use and risk of falls - a prospective study in a large community-dwelling elderly cohort. BMC Geriatr 9:30. doi:10.1186/1471-2318-9-30
46. Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, Schwartz AV, Hanlon JT, Nevitt MC (2002) Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 50(10):1629-1637 (Pubitemid 35192533)
47. Boyle N, Naganathan V, Cumming RG (2010) Medication and falls: risk and optimization. Clin Geriatr Med 26(4):583-605. doi:10.1016/j.cger.2010.06.007
48. Svarstad BL, Mount JK (2001) Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc 49(12):1673-1678 (Pubitemid 34007995)
49. Anthierens S, Pasteels I, Habraken H, Steinberg P, Declercq T, Christiaens T (2010) Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia. Family physicians' attitudes toward benzodiazepine prescribing. Can Fam Phys 56(11):E398-E406
50. Iliffe S, Curran HV, Collins R, Kee SCY, Fletcher S, Woods B (2004) Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Mental Health 8(3):242-248. doi:10.1080/13607860410001669778 (Pubitemid 38639439)
51. Cormack MA, Owens RG, Dewey ME (1989) The effect of minimal interventions by general practitioners on long-term benzodiazepine use. J R Coll Gen Pract 39(327):408-411 (Pubitemid 19255040)
52. Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, van den Hoogen HJ, Mulder J, Breteler MH, Zitman FG (2005) Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug and Alcohol Depend 78(1):49-56. doi:10.1016/j.drugalcdep.2004.09.001 (Pubitemid 40354176)
53. Denis C, Fatseas M, Lavie E, Auriacombe M (2006) Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev 3: CD005194 doi:10.1002/14651858.CD005194. pub2
54. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL (2006) Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 29 (11):1398-1414 (Pubitemid 44764665)
55. Mendelson WB (1995) Long-term follow-up of chronic insomnia. Sleep 18(8):698-701
56. Bain KT (2006) Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 4(2):168-192. doi:10.1016/j. amjopharm.2006.06.006 (Pubitemid 44057814)
57. Alessi CA, Schnelle JF (2000) Approach to sleep disorders in the nursing home setting. Review article. Sleep Med Rev 4(1):45-56. doi:10.1053/smrv.1999. 0066 (Pubitemid 30187043)
58. Lyne J, Quinlivan L, Byrne CA, Malone K, Walsh C (2011) Sleep hygiene use in a psychiatry outpatient setting. Ir Med J 104(2):49-50
59. Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M (2009) A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf 18(2):93-103. doi:10.1002/pds.1694
60. Anthierens S, Grypdonck M, De Pauw L, Christiaens T (2009) Perceptions of nurses in nursing homes on the usage of benzodiazepines. J Clin Nurs 18(22):3098-3106. doi:10.1111/j.1365-2702.2008.02758.x
61. Verrue CL, Petrovic M, Mehuys E, Remon JP, Vander Stichele R (2009) Pharmacists' interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging 26(1):37-49. doi:10.2165/0002512-200926010- 000032613